Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Control of glucose metabolism is important in tenogenic differentiation of progenitors derived from human injured tendons.

Izumi S, Otsuru S, Adachi N, Akabudike N, Enomoto-Iwamoto M.

PLoS One. 2019 Mar 18;14(3):e0213912. doi: 10.1371/journal.pone.0213912. eCollection 2019.

2.

Intervertebral disc regeneration with an adipose mesenchymal stem cell-derived tissue-engineered construct in a rat nucleotomy model.

Ishiguro H, Kaito T, Yarimitsu S, Hashimoto K, Okada R, Kushioka J, Chijimatsu R, Takenaka S, Makino T, Sakai Y, Moriguchi Y, Otsuru S, Hart DA, Fujie H, Nakamura N, Yoshikawa H.

Acta Biomater. 2019 Mar 15;87:118-129. doi: 10.1016/j.actbio.2019.01.050. Epub 2019 Jan 25.

PMID:
30690206
3.

Possible Contribution of Wnt-Responsive Chondroprogenitors to the Postnatal Murine Growth Plate.

Usami Y, Gunawardena AT, Francois NB, Otsuru S, Takano H, Hirose K, Matsuoka M, Suzuki A, Huang J, Qin L, Iwamoto M, Yang W, Toyosawa S, Enomoto-Iwamoto M.

J Bone Miner Res. 2019 May;34(5):964-974. doi: 10.1002/jbmr.3658. Epub 2019 Jan 28.

4.

Endoplasmic reticulum stress is induced in growth plate hypertrophic chondrocytes in G610C mouse model of osteogenesis imperfecta.

Scheiber AL, Guess AJ, Kaito T, Abzug JM, Enomoto-Iwamoto M, Leikin S, Iwamoto M, Otsuru S.

Biochem Biophys Res Commun. 2019 Jan 29;509(1):235-240. doi: 10.1016/j.bbrc.2018.12.111. Epub 2018 Dec 20.

PMID:
30579604
5.

Clinical and angiographic outcomes of true vs. false lumen stenting of coronary chronic total occlusions: Insights from intravascular ultrasound.

Sabbah M, Tada T, Kadota K, Kubo S, Otsuru S, Hasegawa D, Habara S, Tanaka H, Fuku Y, Goto T.

Catheter Cardiovasc Interv. 2019 Feb 15;93(3):E120-E129. doi: 10.1002/ccd.27861. Epub 2018 Oct 22.

PMID:
30345649
6.

Optical Coherence Tomography Predictors for Recurrent Restenosis After Paclitaxel-Coated Balloon Angioplasty for Drug-Eluting Stent Restenosis.

Miura K, Tada T, Habara S, Kuwayama A, Shimada T, Ohya M, Murai R, Amano H, Kubo S, Otsuru S, Tanaka H, Fuku Y, Goto T, Kadota K.

Circ J. 2018 Oct 25;82(11):2820-2828. doi: 10.1253/circj.CJ-18-0464. Epub 2018 Aug 30.

7.

Impact of retrograde approach on long-term clinical outcomes of patients undergoing coronary chronic total occlusion interventions.

Tanaka H, Ohya M, Kubo S, Miura K, Otsuru S, Habara S, Tada T, Fuku Y, Goto T, Kadota K.

EuroIntervention. 2018 Dec 7;14(11):e1183-e1191. doi: 10.4244/EIJ-D-18-00534.

8.

Apolipoprotein E plays crucial roles in maintaining bone mass by promoting osteoblast differentiation via ERK1/2 pathway and by suppressing osteoclast differentiation via c-Fos, NFATc1, and NF-κB pathway.

Noguchi T, Ebina K, Hirao M, Otsuru S, Guess AJ, Kawase R, Ohama T, Yamashita S, Etani Y, Okamura G, Yoshikawa H.

Biochem Biophys Res Commun. 2018 Sep 5;503(2):644-650. doi: 10.1016/j.bbrc.2018.06.055. Epub 2018 Jun 15.

PMID:
29906458
9.

Bone marrow-derived mononuclear cell seeded bioresorbable vascular graft improves acute graft patency by inhibiting thrombus formation via platelet adhesion.

Miyachi H, Reinhardt JW, Otsuru S, Tara S, Nakayama H, Yi T, Lee YU, Miyamoto S, Shoji T, Sugiura T, Breuer CK, Shinoka T.

Int J Cardiol. 2018 Sep 1;266:61-66. doi: 10.1016/j.ijcard.2018.01.059.

10.

In-Hospital Bleeding and Utility of a Maintenance Dose of Prasugrel 2.5 mg in High Bleeding Risk Patients With Acute Coronary Syndrome.

Ohya M, Shimada T, Osakada K, Kuwayama A, Miura K, Murai R, Amano H, Kubo S, Otsuru S, Habara S, Tada T, Tanaka H, Fuku Y, Katoh H, Goto T, Kadota K.

Circ J. 2018 Jun 25;82(7):1874-1883. doi: 10.1253/circj.CJ-18-0114. Epub 2018 Apr 26.

11.

Intratumoral Delivery of Interferonγ-Secreting Mesenchymal Stromal Cells Repolarizes Tumor-Associated Macrophages and Suppresses Neuroblastoma Proliferation In Vivo.

Relation T, Yi T, Guess AJ, La Perle K, Otsuru S, Hasgur S, Dominici M, Breuer C, Horwitz EM.

Stem Cells. 2018 Jun;36(6):915-924. doi: 10.1002/stem.2801. Epub 2018 Feb 27.

12.

Identification of a murine CD45-F4/80lo HSC-derived marrow endosteal cell associated with donor stem cell engraftment.

Overholt KM, Otsuru S, Olson TS, Guess AJ, Velazquez VM, Desbourdes L, Dominici M, Horwitz EM.

Blood Adv. 2017 Dec 14;1(27):2667-2678. doi: 10.1182/bloodadvances.2017008730. eCollection 2017 Dec 26.

13.

Two-Year Outcomes and Predictors of Target Lesion Revascularization for Non-Left Main Coronary Bifurcation Lesions Following Two-Stent Strategy With 2nd-Generation Drug-Eluting Stents.

Ohya M, Morimoto T, Kubo S, Habara S, Kuwayama A, Miura K, Shimada T, Amano H, Otsuru S, Tada T, Tanaka H, Fuku Y, Goto T, Kadota K.

Circ J. 2018 Feb 23;82(3):798-806. doi: 10.1253/circj.CJ-17-1092. Epub 2017 Dec 19.

14.

Relationship between n-3 Polyunsaturated Fatty Acids and Extent of Vessel Disease in Patients with ST Elevation Myocardial Infarction.

Shimada T, Kadota K, Eguchi H, Osakada K, Kuwayama A, Ohya M, Miura K, Amano H, Kubo S, Ozaki M, Hyodo Y, Yoshino M, Miyake K, Kawase Y, Ohashi N, Otsuru S, Tasaka H, Habara S, Tada T, Tanaka H, Maruo T, Fuku Y, Katoh H, Fujii S, Goto T, Mitsudo K.

Int Heart J. 2017 Dec 12;58(6):868-873. doi: 10.1536/ihj.16-565. Epub 2017 Nov 17.

15.

Extracellular vesicles released from mesenchymal stromal cells stimulate bone growth in osteogenesis imperfecta.

Otsuru S, Desbourdes L, Guess AJ, Hofmann TJ, Relation T, Kaito T, Dominici M, Iwamoto M, Horwitz EM.

Cytotherapy. 2018 Jan;20(1):62-73. doi: 10.1016/j.jcyt.2017.09.012. Epub 2017 Oct 26.

PMID:
29107738
16.

ONO-1301 Enhances in vitro Osteoblast Differentiation and in vivo Bone Formation Induced by Bone Morphogenetic Protein.

Kanayama S, Kaito T, Kitaguchi K, Ishiguro H, Hashimoto K, Chijimatsu R, Otsuru S, Takenaka S, Makino T, Sakai Y, Myoui A, Yoshikawa H.

Spine (Phila Pa 1976). 2018 Jun 1;43(11):E616-E624. doi: 10.1097/BRS.0000000000002439.

PMID:
29016438
17.

Clinical and angiographic outcomes of axial stent deformations in unrestricted real world patient population.

Sabbah M, Kadota K, Kubo S, Hyodo Y, Otsuru S, Hasegawa D, Tada T, Habara S, Tanaka H, Fuku Y, Goto T.

J Interv Cardiol. 2017 Dec;30(6):550-557. doi: 10.1111/joic.12445. Epub 2017 Sep 20.

PMID:
28940552
18.

Safety Profile of Good Manufacturing Practice Manufactured Interferon γ-Primed Mesenchymal Stem/Stromal Cells for Clinical Trials.

Guess AJ, Daneault B, Wang R, Bradbury H, La Perle KMD, Fitch J, Hedrick SL, Hamelberg E, Astbury C, White P, Overolt K, Rangarajan H, Abu-Arja R, Devine SM, Otsuru S, Dominici M, O'Donnell L, Horwitz EM.

Stem Cells Transl Med. 2017 Oct;6(10):1868-1879. doi: 10.1002/sctm.16-0485. Epub 2017 Sep 9.

19.

Impact of Dual Antiplatelet Therapy Beyond 1 Year on Clinical Outcomes of Patients With Stent Fracture or Peri-Stent Contrast Staining After Sirolimus-Eluting Stent Implantation.

Fuku Y, Kadota K, Amano H, Kubo S, Otsuru S, Habara S, Tada T, Tanaka H, Goto T.

Circ J. 2017 Dec 25;82(1):211-217. doi: 10.1253/circj.CJ-17-0477. Epub 2017 Aug 31.

20.

Very long-term serial luminal changes after sirolimus-eluting stent implantation and progression process of very late stent failure.

Kubo S, Ohya M, Kuwayama A, Shimada T, Miura K, Amano H, Otsuru S, Habara S, Tada T, Tanaka H, Fuku Y, Goto T, Kadota K.

Cardiovasc Revasc Med. 2018 Jan - Feb;19(1 Pt B):88-94. doi: 10.1016/j.carrev.2017.06.017. Epub 2017 Jul 4.

PMID:
28778392
21.

BMP-2/7 heterodimer strongly induces bone regeneration in the absence of increased soft tissue inflammation.

Kaito T, Morimoto T, Mori Y, Kanayama S, Makino T, Takenaka S, Sakai Y, Otsuru S, Yoshioka Y, Yoshikawa H.

Spine J. 2018 Jan;18(1):139-146. doi: 10.1016/j.spinee.2017.07.171. Epub 2017 Jul 20.

PMID:
28735764
22.

Impact of Stent Type and Presence of Vasospastic Angina on Long-Term Prognosis.

Hata R, Oka N, Kubo S, Kuwayama A, Ohya M, Shimada T, Miura K, Amano H, Hyodo Y, Otsuru S, Habara S, Tada T, Tanaka H, Fuku Y, Goto T, Kadota K.

Circ J. 2018 Jan 25;82(2):469-476. doi: 10.1253/circj.CJ-17-0298. Epub 2017 Jun 28.

23.

Stent Fracture and Peri-Stent Contrast Staining After Everolimus-Eluting Stent Implantation - 5-Year Outcomes.

Miura K, Tada T, Kuwayama A, Shimada T, Ohya M, Amano H, Kubo S, Hyodo Y, Otsuru S, Habara S, Tanaka H, Fuku Y, Goto T, Kadota K.

Circ J. 2017 Sep 25;81(10):1514-1521. doi: 10.1253/circj.CJ-17-0236. Epub 2017 Jun 13.

24.

Modeling and remodeling effects of intermittent administration of teriparatide (parathyroid hormone 1-34) on bone morphogenetic protein-induced bone in a rat spinal fusion model.

Kaito T, Morimoto T, Kanayama S, Otsuru S, Kashii M, Makino T, Kitaguchi K, Furuya M, Chijimatsu R, Ebina K, Yoshikawa H.

Bone Rep. 2016 Jul 16;5:173-180. doi: 10.1016/j.bonr.2016.07.003. eCollection 2016 Dec.

25.

Difference in clinical presentations and related angiographic findings among early, late, and very late sirolimus-eluting stent failures requiring target lesion revascularization.

Kubo S, Ohya M, Kuwayama A, Shimada T, Miura K, Amano H, Hyodo Y, Otsuru S, Habara S, Tada T, Tanaka H, Fuku Y, Goto T, Kadota K.

Int J Cardiol. 2017 Sep 15;243:116-120. doi: 10.1016/j.ijcard.2017.05.052. Epub 2017 May 13.

PMID:
28545849
26.

Long-term (8-10 years) outcomes after biodegradable polymer-coated biolimus-eluting stent implantation.

Ohya M, Kubo S, Kuwayama A, Miura K, Shimada T, Amano H, Hyodo Y, Otsuru S, Habara S, Tada T, Tanaka H, Fuku Y, Katoh H, Goto T, Kadota K.

Heart. 2017 Jul;103(13):1002-1008. doi: 10.1136/heartjnl-2016-310591. Epub 2017 Jan 17.

PMID:
28096181
27.

Late Restenosis After Both First-Generation and Second-Generation Drug-Eluting Stent Implantations Occurs in Patients With Drug-Eluting Stent Restenosis.

Habara S, Kadota K, Kuwayama A, Shimada T, Ohya M, Miura K, Amano H, Kubo S, Hyodo Y, Otsuru S, Tada T, Tanaka H, Fuku Y, Goto T.

Circ Cardiovasc Interv. 2016 Dec;9(12). pii: e004449.

PMID:
27932532
28.

Five-Year Outcomes After Paclitaxel-Coated Balloon Angioplasty for Drug-Eluting Stent Restenosis.

Miura K, Kadota K, Habara S, Shimada T, Ohya M, Amano H, Kubo S, Hyodo Y, Otsuru S, Tada T, Tanaka H, Fuku Y, Goto T.

Am J Cardiol. 2017 Feb 1;119(3):365-371. doi: 10.1016/j.amjcard.2016.10.030. Epub 2016 Nov 1.

PMID:
27894569
29.

Hematopoietic derived cells do not contribute to osteogenesis as osteoblasts.

Otsuru S, Overholt KM, Olson TS, Hofmann TJ, Guess AJ, Velazquez VM, Kaito T, Dominici M, Horwitz EM.

Bone. 2017 Jan;94:1-9. doi: 10.1016/j.bone.2016.10.003. Epub 2016 Oct 7.

PMID:
27725318
30.

Ten-year clinical outcomes after sirolimus-eluting stent implantation: Impact of an in-stent restenosis target lesion.

Miura K, Kadota K, Habara S, Miyawaki H, Shimada T, Ohya M, Amano H, Izawa Y, Hyodo Y, Otsuru S, Hasegawa D, Tada T, Tanaka H, Fuku Y, Goto T, Mitsudo K.

Am Heart J. 2016 May;175:47-55. doi: 10.1016/j.ahj.2016.02.005. Epub 2016 Feb 17.

PMID:
27179723
31.

Incidence, predictive factors, and clinical impact of stent recoil in stent fracture lesion after drug-eluting stent implantation.

Ohya M, Kadota K, Kubo S, Tada T, Habara S, Shimada T, Amano H, Izawa Y, Hyodo Y, Otsuru S, Hasegawa D, Tanaka H, Fuku Y, Goto T, Mitsudo K.

Int J Cardiol. 2016 Jul 1;214:123-9. doi: 10.1016/j.ijcard.2016.03.013. Epub 2016 Mar 25.

PMID:
27060271
32.

Stent Fracture After Sirolimus-Eluting Stent Implantation: 8-Year Clinical Outcomes.

Ohya M, Kadota K, Tada T, Habara S, Shimada T, Amano H, Izawa Y, Hyodo Y, Miyake K, Otsuru S, Hasegawa D, Tanaka H, Maruo T, Katoh H, Fuku Y, Goto T, Mitsudo K.

Circ Cardiovasc Interv. 2015 Aug;8(8):e002664. doi: 10.1161/CIRCINTERVENTIONS.115.002664.

PMID:
26227346
33.

A Tissue-Engineered Chondrocyte Cell Sheet Induces Extracellular Matrix Modification to Enhance Ventricular Biomechanics and Attenuate Myocardial Stiffness in Ischemic Cardiomyopathy.

Shudo Y, Cohen JE, MacArthur JW, Goldstone AB, Otsuru S, Trubelja A, Patel J, Edwards BB, Hung G, Fairman AS, Brusalis C, Hiesinger W, Atluri P, Hiraoka A, Miyagawa S, Sawa Y, Woo YJ.

Tissue Eng Part A. 2015 Oct;21(19-20):2515-25. doi: 10.1089/ten.TEA.2014.0155. Epub 2015 Sep 18.

34.

Late Restenosis After Paclitaxel-Coated Balloon Angioplasty Occurs in Patients With Drug-Eluting Stent Restenosis.

Habara S, Kadota K, Shimada T, Ohya M, Amano H, Izawa Y, Kubo S, Hyodo Y, Otsuru S, Hasegawa D, Tada T, Tanaka H, Fuku Y, Goto T, Mitsudo K.

J Am Coll Cardiol. 2015 Jul 7;66(1):14-22. doi: 10.1016/j.jacc.2015.05.002.

35.

Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.

Tada T, Kadota K, Hosogi S, Miyake K, Ohya M, Amano H, Izawa Y, Kanazawa T, Kubo S, Ichinohe T, Hyoudou Y, Hayakawa Y, Sabbah MM, Otsuru S, Hasegawa D, Habara S, Tanaka H, Fuku Y, Katoh H, Goto T, Mitsudo K.

Eur Heart J Cardiovasc Imaging. 2015 Oct;16(10):1101-11. doi: 10.1093/ehjci/jev031. Epub 2015 Mar 9.

PMID:
25762559
36.

Paclitaxel-coated balloon catheter compared with drug-eluting stent for drug-eluting stent restenosis in routine clinical practice.

Habara S, Kadota K, Kanazawa T, Ichinohe T, Kubo S, Hyodo Y, Otsuru S, Hasegawa D, Tada T, Tanaka H, Fuku Y, Goto T, Mitsudo K.

EuroIntervention. 2016 Feb;11(10):1098-105. doi: 10.4244/EIJY15M02_09.

37.

Genomic and functional comparison of mesenchymal stromal cells prepared using two isolation methods.

Otsuru S, Hofmann TJ, Raman P, Olson TS, Guess AJ, Dominici M, Horwitz EM.

Cytotherapy. 2015 Mar;17(3):262-70. doi: 10.1016/j.jcyt.2014.10.013.

PMID:
25659640
38.

Everolimus-eluting stent implantation versus repeat paclitaxel-coated balloon angioplasty for recurrent in-stent restenosis lesion caused by paclitaxel-coated balloon failure.

Kubo S, Kadota K, Otsuru S, Hasegawa D, Habara S, Tada T, Tanaka H, Fuku Y, Katoh H, Goto T, Mitsudo K.

EuroIntervention. 2015 Jan;10(9):e1-8. doi: 10.4244/EIJV10I9A180.

39.

Detection of microparticles from human red blood cells by multiparametric flow cytometry.

Grisendi G, Finetti E, Manganaro D, Cordova N, Montagnani G, Spano C, Prapa M, Guarneri V, Otsuru S, Horwitz EM, Mari G, Dominici M.

Blood Transfus. 2015 Apr;13(2):274-80. doi: 10.2450/2014.0136-14. Epub 2014 Oct 23.

40.

Clinical and angiographic outcomes after drug-eluting stent implantation with triple-kissing-balloon technique for left main trifurcation lesion: comparison of single-stent and multi-stent procedures.

Kubo S, Kadota K, Sabbah M, Otsuru S, Hasegawa D, Habara S, Tada T, Tanaka H, Fuku Y, Katoh H, Goto T, Mitsudo K.

J Invasive Cardiol. 2014 Nov;26(11):571-8.

41.

Tendon progenitor cells in injured tendons have strong chondrogenic potential: the CD105-negative subpopulation induces chondrogenic degeneration.

Asai S, Otsuru S, Candela ME, Cantley L, Uchibe K, Hofmann TJ, Zhang K, Wapner KL, Soslowsky LJ, Horwitz EM, Enomoto-Iwamoto M.

Stem Cells. 2014 Dec;32(12):3266-77. doi: 10.1002/stem.1847.

42.

Thirty-day outcome of transcatheter aortic valve implantation with the edwards SAPIEN XT prosthesis via the transiliofemoral approach.

Fuku Y, Goto T, Komiya T, Sakaguchi G, Shimamoto T, Maruo T, Hasegawa D, Otsuru S, Saito N, Hyodo Y, Ueno G, Kadota K, Mitsudo K.

Circ J. 2014;78(6):1357-63. Epub 2014 Apr 3.

43.

Optimal treatment of recurrent restenosis lesions after drug-eluting stent implantation for in-stent restenosis lesions.

Kubo S, Kadota K, Otsuru S, Hasegawa D, Shigemoto Y, Habara S, Tada T, Tanaka H, Fuku Y, Katoh H, Goto T, Mitsudo K.

EuroIntervention. 2013 Nov;9(7):788-96. doi: 10.4244/EIJV9I7A131.

44.

Comparison of long-term outcome after percutaneous coronary intervention for stent thrombosis between early, late, and very late stent thrombosis.

Kubo S, Kadota K, Ichinohe T, Miyake K, Hyodo Y, Otsuru S, Hasegawa D, Shigemoto Y, Habara S, Tada T, Tanaka H, Fuku Y, Katoh H, Fujii S, Goto T, Mitsudo K.

Circ J. 2014;78(1):101-9. Epub 2013 Nov 2.

45.

Association between tissue characteristics evaluated with optical coherence tomography and mid-term results after paclitaxel-coated balloon dilatation for in-stent restenosis lesions: a comparison with plain old balloon angioplasty.

Tada T, Kadota K, Hosogi S, Miyake K, Amano H, Nakamura M, Izawa Y, Kubo S, Ichinohe T, Hyoudou Y, Eguchi H, Hayakawa Y, Otsuru S, Hasegawa D, Shigemoto Y, Habara S, Tanaka H, Fuku Y, Kato H, Goto T, Mitsudo K.

Eur Heart J Cardiovasc Imaging. 2014 Mar;15(3):307-15. doi: 10.1093/ehjci/jet165. Epub 2013 Sep 15.

PMID:
24042176
46.

Delayed marrow infusion in mice enhances hematopoietic and osteopoietic engraftment by facilitating transient expansion of the osteoblastic niche.

Marino R, Otsuru S, Hofmann TJ, Olson TS, Rasini V, Veronesi E, Boyd K, Gaber MW, Martinez C, Paolucci P, Dominici M, Horwitz EM.

Biol Blood Marrow Transplant. 2013 Nov;19(11):1566-73. doi: 10.1016/j.bbmt.2013.07.025. Epub 2013 Aug 2.

47.

IGF-1-mediated osteoblastic niche expansion enhances long-term hematopoietic stem cell engraftment after murine bone marrow transplantation.

Caselli A, Olson TS, Otsuru S, Chen X, Hofmann TJ, Nah HD, Grisendi G, Paolucci P, Dominici M, Horwitz EM.

Stem Cells. 2013 Oct;31(10):2193-204. doi: 10.1002/stem.1463.

48.

Seven-year clinical outcomes of unprotected left main coronary artery stenting with drug-eluting stent and bare-metal stent.

Kubo S, Kadota K, Shimada T, Ozaki M, Ichinohe T, Eguchi H, Miyake K, Hyodo Y, Saito N, Otsuji H, Otsuru S, Hasegawa D, Shigemoto Y, Habara S, Tada T, Tanaka H, Fuku Y, Katoh H, Yamamoto H, Fujii S, Goto T, Mitsudo K.

Circ J. 2013;77(10):2497-504. Epub 2013 Jun 25.

49.

Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning.

Olson TS, Caselli A, Otsuru S, Hofmann TJ, Williams R, Paolucci P, Dominici M, Horwitz EM.

Blood. 2013 Jun 27;121(26):5238-49. doi: 10.1182/blood-2012-10-463414. Epub 2013 May 10.

50.

Transplanted murine long-term repopulating hematopoietic cells can differentiate to osteoblasts in the marrow stem cell niche.

Hofmann TJ, Otsuru S, Marino R, Rasini V, Veronesi E, Murgia A, Lahti J, Boyd K, Dominici M, Horwitz EM.

Mol Ther. 2013 Jun;21(6):1224-31. doi: 10.1038/mt.2013.36. Epub 2013 Apr 16.

Supplemental Content

Loading ...
Support Center